Well I am surprised this has gone down on such good news. 'Theoretically' the sign of a weak stock - oh well just have to look for a top into my LT holdings.
My reading of it is phase 1/2 human tropical with phase 1 human IV in parallel / side by side. They are not so specific on IV timelines etc in IV ann said screening Q4 2020 so could be happening now & 48 IV test candidates ready to run 'in parallel' with 30 tropical candidates. 'in parallel' is open to interpretation at present.
A$30 Mil in the bank to progress this, have the green light for phase 1 & 2 human tropic & phase 1 human IV 'in parallel' - I'm liking it.
IV
https://themarketherald.com.au/recce-pharmaceuticals-asxrce-enlists-cmax-clinical-research-for-phase-1-study-2020-09-11/
.
.
- Forums
- ASX - By Stock
- RCE
- Ann: HREC Approval to Start Phase I/II Burns Wound Study
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Ann: HREC Approval to Start Phase I/II Burns Wound Study, page-33
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online